Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 4/20 | 0.69 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.69 |
| ▸ | CNR2 | P34972 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.59 |
| ▸ | F7 | P08709 | 3/20 | 0.59 |
| ▸ | F3 | P13726 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 3/20 | 0.59 |
| ▸ | PPARG | P37231 | 2/20 | 0.59 |
| ▸ | PPARD | Q03181 | 2/20 | 0.59 |
| ▸ | PPARA | Q07869 | 2/20 | 0.59 |
| ▸ | FABP3 | P05413 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.59 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.59 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.59 |
| ▸ | FABP4 | P15090 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2701949 | 1.00 | CNR1 (0.69) | CNR1TRPV1CNR2ALDH1A1KDM4E | |
| SCHEMBL338570 | 1.00 | CNR1 (0.69) | CNR1TRPV1CNR2ALDH1A1KDM4E | |
| SCHEMBL2712335 | 0.95 | CNR1 (0.76) | CNR1TRPV1CNR2ALDH1A1KDM4E | |
| SCHEMBL874378 | 0.95 | CNR1 (0.61) | CNR1TRPV1CNR2F7F3 | |
| SCHEMBL10613227 | 0.95 | CNR1 (0.61) | CNR1TRPV1CNR2F7F3 | |
| SCHEMBL10457976 | 0.95 | CNR1 (0.61) | CNR1TRPV1CNR2F7F3 | |
| SCHEMBL1614760 | 0.95 | CNR1 (0.61) | CNR1TRPV1CNR2F7F3 | |
| SCHEMBL10432515 | 0.95 | CNR1 (0.61) | CNR1TRPV1CNR2F7F3 | |
| SCHEMBL757458 | 0.95 | CNR1 (0.61) | CNR1TRPV1CNR2F7F3 | |
| SCHEMBL8115798 | 0.94 | CNR1 (0.60) | CNR1TRPV1CNR2F7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12214067-B2 | Oil-in-water emulsion sunscreen composition | ISP INVESTMENTS INC. (US) | 2025-02-04 | — | — | US | claimed |
| US-20240374492-A1 | A SUNSCREEN COMPOSITION COMPRISING AVOBENZONE AND A METHOD FOR PHOTOSTABILIZATION | ISP INVESTMENTS LLC (US) | 2024-11-14 | — | — | US | claimed |
| WO-2023009315-A1 | A SUNSCREEN COMPOSITION COMPRISING AVOBENZONE AND A METHOD FOR PHOTOSTABILIZATION | ISP INVESTMENTS LLC (US) | 2023-02-02 | — | — | WO | claimed |
| US-20220387290-A1 | SUNSCREEN COMPOSITIONS AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2022-12-08 | — | — | US | claimed |
| US-20220370965-A1 | METHOD, SYSTEM, APPARATUS AND FORMULATIONS FOR PRODUCING OIL-BASED BLENDS AND MICROEMULSIONS AND NANOEMULSIONS | FERNANDES SERODIO JOAO CARLOS (GB) | 2022-11-24 | — | — | US | claimed |
| EP-4055127-A1 | METHOD, SYSTEM, APPARATUS AND FORMULATIONS FOR PRODUCING OIL-BASED BLENDS AND MICROEMULSIONS AND NANOEMULSIONS | Fernandes Serodio, Joao Carlos (GB) | 2022-09-14 | — | — | EP | claimed |
| EP-3946642-A1 | SUNSCREEN COMPOSITIONS AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2022-02-09 | — | — | EP | claimed |
| EP-2395966-B1 | COSMETIC COMPOSITION FOR SKIN CARE | LENGHEIM HUBERT (AT) | 2016-07-06 | — | — | EP | claimed |
| WO-2010091827-A2 | COSMETIC FORMULATION FOR SKIN CARE | LENGHEIM HUBERT (AT) | 2010-08-19 | — | — | WO | claimed |
| US-12629383-B2 | Cannabinoid compositions with high solubility and bioavailability | PISAK MEHMET NEVZAT (TR) | 2026-05-19 | — | — | US | disclosed |
| US-12624236-B2 | Inkjet inks for opaque printed images | KAO CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-3600224-B1 | SKIN CARE COMPOSITIONS COMPRISING A TERPOLYMER, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2026-05-06 | — | — | EP | disclosed |
| US-12595385-B2 | Inkjet inks | KAO CORPORATION (JP) | 2026-04-07 | — | — | US | disclosed |
| WO-2026044006-A1 | MODIFIED STARCH COMPOUNDS AND USES THEREOF | ISP INVESTMENTS LLC (US) | 2026-02-26 | — | — | WO | disclosed |
| US-20180134991-A1 | Petroleum Distillates With Increased Solvency | BANCFIRST | 2018-05-17 | — | — | US | disclosed |
| US-20170119643-A1 | DETOXIFICATION OF MICROBIAL VIRULENCE FACTORS IN ORAL CAVITY | THE PROCTER & GAMBLE COMPANY | 2017-05-04 | — | — | US | disclosed |
| EP-2395966-B1 | COSMETIC COMPOSITION FOR SKIN CARE | LENGHEIM HUBERT (AT) | 2016-07-06 | — | — | EP | disclosed |
| CN-105484066-A | Environment-friendly dyeing method adopting hinos blue | SHANGHAI HINOS CLOTHING CO LTD | 2016-04-13 | — | — | CN | disclosed |
| CN-105219014-A | Anti-static ABS plastic and preparation method thereof | SHANGHAI HANS MOLDING CO LTD | 2016-01-06 | — | — | CN | disclosed |
| WO-2010091827-A2 | COSMETIC FORMULATION FOR SKIN CARE | LENGHEIM HUBERT (AT) | 2010-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624236-B2 | Inkjet inks for opaque printed images | MKI67, MARK1, MYB | CNR1 3833/4885TRPV1 1953/4885CNR2 4278/4885 |
| US-12595385-B2 | Inkjet inks | EBP, ADRA1D, ADRA1A | CNR1 2199/4885TRPV1 2299/4885CNR2 2637/4885 |
| US-12629383-B2 | Cannabinoid compositions with high solubility and bioavailability | CNR1, GPR55, CNR2 | CNR1 1/4885TRPV1 210/4885CNR2 3/4885 |
| US-20170119643-A1 | DETOXIFICATION OF MICROBIAL VIRULENCE FACTORS IN ORAL CAVITY | GSTM2, GSTA2, GSTA1 | CNR1 3027/4885TRPV1 2214/4885CNR2 2622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.